Literature DB >> 12621008

Initial experience with oral contrast in PET/CT: phantom and clinical studies.

Christian Cohade1, Medhat Osman, Yuji Nakamoto, Laura T Marshall, Jonathan M Links, Elliot K Fishman, Richard L Wahl.   

Abstract

UNLABELLED: The aims of the study were to evaluate the effects of oral contrast on apparent tracer activity measured with PET/CT when using CT attenuation correction and to report our initial experience in the use of oral contrast with PET/CT.
METHODS: Phantom studies with (18)F activity and saline bags or syringes filled with barium or gastrografin of varying densities were performed using a PET/CT scanner (CT attenuation correction). In the study, 91 clinical patients received dilute oral contrast and were evaluated by whole-body (18)F-FDG PET.
RESULTS: A phantom experiment with CT contrast (1.3% weight/volume [w/v] barium) showed a "cold" area in the cold stomach whereas a phantom with high-density barium (98% w/v) showed an artifactual focus of intense "activity" in the cold stomach. In clinical studies, stomach and right colon were opacified by CT contrast. Maximal measured contrast density was 239 Hounsfield units.
CONCLUSION: High-density barium causes overestimation of tissue (18)F-FDG concentration. Low-density barium does not cause significant artifacts and appears suitable for clinical use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621008

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

Review 1.  PET/CT: a new imaging technology in nuclear medicine.

Authors:  Heiko Schöder; Yusuf E Erdi; Steven M Larson; Henry W D Yeung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-05       Impact factor: 9.236

2.  Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?

Authors:  Patrick Reinartz; Franz-Josef Wieres; Wolfram Schneider; Alexander Schur; Ulrich Buell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-10       Impact factor: 9.236

3.  The new-generation positron emission tomography/computed tomography scanners: implications for cardiac imaging.

Authors:  Stephen L Bacharach
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

4.  Calcified Lymph Nodes Causing Clinically Relevant Attenuation Correction Artifacts on PET/CT Imaging.

Authors:  Amar Mehta; Ajeet Mehta; Charles Laymon; Todd M Blodgett
Journal:  J Radiol Case Rep       Date:  2010-02-01

5.  Oral contrast medium in PET/CT: should you or shouldn't you?

Authors:  Ashley M Groves; Irfan Kayani; John C Dickson; Caroline Townsend; Ian Croasdale; Rizwan Syed; Nagesh Nagabushan; Sharon F Hain; Peter J Ell; Jamshed B Bomanji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-04       Impact factor: 9.236

6.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

7.  Delayed imaging with oral contrast improves [68Ga]Ga-DOTANOC PET/CT detection of primary duodenal neuroendocrine tumor (NET).

Authors:  Riccardo Mei; Vincenzo Allegri; Diletta Calabrò; Stefano Fanti; Valentina Ambrosini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-09       Impact factor: 9.236

8.  PET/CT artifacts.

Authors:  Todd M Blodgett; Ajeet S Mehta; Amar S Mehta; Charles M Laymon; Jonathan Carney; David W Townsend
Journal:  Clin Imaging       Date:  2011 Jan-Feb       Impact factor: 1.605

Review 9.  Utility of positron emission tomography/CT in the evaluation of small bowel pathology.

Authors:  C G Cronin; J Scott; A Kambadakone; O A Catalano; D Sahani; M A Blake; S McDermott
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

Review 10.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.